In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids
Authors:
- Michelle RocheMichelle Roche
- Michael DiamondMDMichael Diamond
- John P. KellyJKJohn P. Kelly
- David P. FinnDFDavid P. Finn
- 1 December 2006
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 181 (1-2) , 57-67
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Interleukin-2 Suppression by 2-Arachidonyl Glycerol Is Mediated through Peroxisome Proliferator-Activated Receptor γ Independently of Cannabinoid Receptors 1 and 2Molecular Pharmacology, 2006
- Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosisThe FASEB Journal, 2005
- Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 2005
- Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptorBritish Journal of Pharmacology, 2003
- Cytokine-to-brain communication: A review & analysis of alternative mechanismsLife Sciences, 1995
- Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte SubpopulationsEuropean Journal of Biochemistry, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivoJournal of Toxicology and Environmental Health, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976